SZodixStudyAcademic Library
ShelvesOpen access
Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated
The effect of Citalopram in panic disorder
9 references·16 citing·46 second hop
The effect of Citalopram in panic disorder (1997)The effect of Citalopram in panic disorderParoxetine in the Treatment of Panic Disorder a Randomised, Double-Blind, Placebo-Controlled Study (1995)Paroxetine in the Treatment o…Alprazolam and Exposure Alone and Combined in Panic Disorder with Agoraphobia (1993)Alprazolam and Exposure Alone…Drug Treatment of Panic Disorder: Comparative Efficacy of Alprazolam, Imipramine, and Placebo (1992)Drug Treatment of Panic Disor…The Hamilton Anxiety Scale: reliability, validity and sensitivity to change in anxiety and depressive disorders (1988)The Hamilton Anxiety Scale: r…Alprazolam in Panic Disorder and Agoraphobia: Results From a Multicenter Trial (1988)Alprazolam in Panic Disorder …The Anxiety Disease (1984)The Anxiety DiseaseThe Clinical Anxiety Scale: An Instrument Derived from the Hamilton Anxiety Scale (1982)The Clinical Anxiety Scale: A…A New Depression Scale Designed to be Sensitive to Change (1979)A New Depression Scale Design…THE ASSESSMENT OF ANXIETY STATES BY RATING (1959)THE ASSESSMENT OF ANXIETY STA…Antidepressants versus placebo for panic disorder in adults (2018)Antidepressants versus placeb…Advancing the defensive explanation for anxiety disorders: lorazepam effects on human defense are systematically modulated by personality and threat-type (2013)Advancing the defensive expla…A facial expression for anxiety. (2012)A facial expression for anxie…Effects of Lorazepam and Citalopram on Human Defensive Reactions: Ethopharmacological Differentiation of Fear and Anxiety (2009)Effects of Lorazepam and Cita…Anxiety disorders: a comprehensive review of pharmacotherapies (2008)Anxiety disorders: a comprehe…A double-blind study of the efficacy of venlafaxine extended-release, paroxetine, and placebo in the treatment of panic disorder (2006)A double-blind study of the e…Antiepileptic Drugs in the Treatment of Anxiety Disorders (2004)Antiepileptic Drugs in the Tr…Escitalopram in the Treatment of Panic Disorder (2003)Escitalopram in the Treatment…Australian and New Zealand Clinical Practice Guidelines for the Treatment of Panic Disorder and Agoraphobia (2003)Australian and New Zealand Cl…Comparison of Response to a Selective Serotonin Reuptake Inhibitor in Children, Adolescents, and Adults with Posttraumatic Stress Disorder (2002)Comparison of Response to a S…Anxiety disorders and major depression, together or apart (2001)Anxiety disorders and major d…Phobic disorders and panic in adults: A guide to assessment and treatment. (2000)Phobic disorders and panic in…Sertraline in the treatment of panic disorder (1998)Sertraline in the treatment o…Serotonin and panic (1998)Serotonin and panicOutcome Assessment and Clinical Improvement in Panic Disorder: Evidence From a Randomized Controlled Trial of Fluoxetine and Placebo (1998)Outcome Assessment and Clinic…Effects of citalopram treatment on behavioural, cardiovascular and neuroendocrine response to cholecystokinin tetrapeptide challenge in patients with panic disorder. (1997)Effects of citalopram treatme…ECDEU Assessment Manual (1976)ON THE METHODS AND THEORY OF RELIABILITY (1976)Review of Psychometric theory (2nd ed.). (1979)Development and validation of the Geriatric Anxiety Inventory (2006)Music therapy for depression (2017)Sensitivity to change and minimal clinically important difference of the 7-item Generalized Anxiety Disorder Questionnaire (GAD-7) (2020)Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Text Revision (DSM-IV-TR) (2000)Current use of benzodiazepines in anxiety disorders (2008)Socially Anxious Primary Care Patients’ Attitudes Toward Cognitive Bias Modification (CBM): A Qualitative Study (2011)Diagnostic and Statistical Manual of Mental Disorders (2013)Systematic review and meta-analysis: Dose-response curve of SSRIs and SNRIs in anxiety disorders (2018)A Rating Instrument For Anxiety Disorders (1971)ECDEU Assessment Manual for Psychopharmacology (1976)Cognitive therapy of anxiety disorders. (1993)Double-Blind, Fixed-Dose, Placebo-Controlled Study of Paroxetine in the Treatment of Panic Disorder (1998)Propranolol for the treatment of anxiety disorders: Systematic review and meta-analysis (2015)Royal Australian and New Zealand College of Psychiatrists clinical practice guidelines for the treatment of panic disorder, social anxiety disorder and generalised anxiety disorder (2018)Delineation of two drug-responsive anxiety syndromes (1964)SCL-90: an outpatient psychiatric rating scale--preliminary report. (1973)Brief standard self-rating for phobic patients (1979)A meta-analysis of treatment outcome for panic disorder (1995)Assessing treatment effects in clinical trials with the Discan metric of the Sheehan Disability Scale (2008)A RATING SCALE FOR DEPRESSION (1960)An Inventory for Measuring Depression (1961)Cognitive-behavioral and pharmacological treatment for social phobia: A meta-analysis. (1997)A meta-analysis of the efficacy of psycho- and pharmacotherapy in panic disorder with and without agoraphobia (2005)Enduring Effects for Cognitive Behavior Therapy in the Treatment of Depression and Anxiety (2005)Book Review: Measurement and Classification of Psychiatric Symptoms (1975)Trait-State Artifacts and the Diagnosis of Personality Disorders (1991)A Comparison of Fluvoxamine, Cognitive Therapy, and Placebo in the Treatment of Panic Disorder (1993)Combination of behaviour therapy with fluvoxamine in comparison with behaviour therapy and placebo (1998)Development of a Rating Scale for Primary Depressive Illness (1967)Diagnostic Criteria for Use in Psychiatric Research (1972)The PHQ-9 (2001)The PHQ-9: A New Depression Diagnostic and Severity Measure (2002)The validity of the Hospital Anxiety and Depression Scale (2002)Research Diagnostic Criteria (1978)Subtyping of Panic Disorder by Symptom Profile (1993)A Risk-Benefit Assessment of Buspirone in the Treatment of Anxiety Disorders (1997)Paroxetine efficacy in the treatment of generalized anxiety disorder (1997)Development and validation of the penn state worry questionnaire (1990)Psychometric properties of the 42-item and 21-item versions of the Depression Anxiety Stress Scales in clinical groups and a community sample. (1998)A Brief Measure for Assessing Generalized Anxiety Disorder (2006)Social Phobia (1985)Development and validation of an Overall Anxiety Severity And Impairment Scale (OASIS) (2006)Internet addiction and problematic Internet use: A systematic review of clinical research (2016)
this work references cited by second hop

References

  • 1979A New Depression Scale Designed to be Sensitive to Change13,964 cited
  • 1959THE ASSESSMENT OF ANXIETY STATES BY RATING11,442 cited
  • 1988The Hamilton Anxiety Scale: reliability, validity and sensitivity to change in anxiety and depressive disorders1,042 cited
  • 1984The Anxiety Disease883 cited
  • 1988Alprazolam in Panic Disorder and Agoraphobia: Results From a Multicenter Trial564 cited
  • 1993Alprazolam and Exposure Alone and Combined in Panic Disorder with Agoraphobia478 cited
  • 1982The Clinical Anxiety Scale: An Instrument Derived from the Hamilton Anxiety Scale265 cited
  • 1995Paroxetine in the Treatment of Panic Disorder a Randomised, Double-Blind, Placebo-Controlled Study262 cited
  • 1992Drug Treatment of Panic Disorder: Comparative Efficacy of Alprazolam, Imipramine, and Placebo228 cited

Cited by

  • 2008Anxiety disorders: a comprehensive review of pharmacotherapies149 cited
  • 1998Sertraline in the treatment of panic disorder142 cited
  • 2000Phobic disorders and panic in adults: A guide to assessment and treatment.141 cited
  • 2003Escitalopram in the Treatment of Panic Disorder139 cited
  • 1998Outcome Assessment and Clinical Improvement in Panic Disorder: Evidence From a Randomized Controlled Trial of Fluoxetine and Placebo124 cited

Only edges whose both ends are imported exist here. Widen the year window, or show the whole map. Back to the work

  • 2002Comparison of Response to a Selective Serotonin Reuptake Inhibitor in Children, Adolescents, and Adults with Posttraumatic Stress Disorder117 cited
  • 1997Effects of citalopram treatment on behavioural, cardiovascular and neuroendocrine response to cholecystokinin tetrapeptide challenge in patients with panic disorder.116 cited
  • 2012A facial expression for anxiety.113 cited
  • 2001Anxiety disorders and major depression, together or apart108 cited
  • 2006A double-blind study of the efficacy of venlafaxine extended-release, paroxetine, and placebo in the treatment of panic disorder103 cited
  • 1998Serotonin and panic95 cited
  • 2013Advancing the defensive explanation for anxiety disorders: lorazepam effects on human defense are systematically modulated by personality and threat-type87 cited
  • 2009Effects of Lorazepam and Citalopram on Human Defensive Reactions: Ethopharmacological Differentiation of Fear and Anxiety79 cited
  • 2003Australian and New Zealand Clinical Practice Guidelines for the Treatment of Panic Disorder and Agoraphobia79 cited
  • 2004Antiepileptic Drugs in the Treatment of Anxiety Disorders78 cited
  • 2018Antidepressants versus placebo for panic disorder in adults76 cited